Canadian Urological Association Journal
Perioperative and oncologic outcomes with robotic vs. open radical prostatectomy
By Amanda Elizabeth Hird, Rano Matta, Sarah Neu and 9 others.
Abstract
Introduction
Robotic-assisted radical prostatectomy (RARP) is the predominant surgical treatment for localized prostate cancer worldwide, but adoption has been slower in Ontario due to funding constraints. This setting enables population-level comparison of RARP and open radical prostatectomy (ORP). We evaluated perioperative and short-term oncologic outcomes for men undergoing radical prostatectomy in Ontario between April 2017 and March 2024.
Methods
We conducted a retrospective cohort study of all patients who underwent publicly funded radical prostatectomy for localized prostate cancer. Co-primary outcomes were blood transfusion rates and hospital length of stay (LOS). Secondary outcomes included operative time, 30-day readmission, vesico-urethral anastomosis stenosis (VUAS) requiring intervention, surgical wait time, and travel distance. Exploratory outcomes included 30-day mortality, positive surgical margins (PSM), and receipt of pelvic radiation post-prostatectomy.